Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: A new drug interaction?

M. Simõn-Talero, M. Buti, R. Esteban

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)

Abstract

Treatment for hepatitis C virus is often complicated by anaemia from ribavirin-related haemolysis and bone marrow suppression because of peginterferon alfa. An extensive literature search revealed no reports of drug interactions between ribavirin and oseltamivir. We report the case of a patient with chronic hepatitis C infection who developed severe anaemia during antiviral treatment with peginterferon alfa/ribavirin when oseltamivir was added to treat influenza. The adverse events related to ribavirin and drug-drug interactions during therapy for hepatitis C are discussed. © 2012 Blackwell Publishing Ltd.
Original languageEnglish
Pages (from-to)14-17
JournalJournal of Viral Hepatitis
Volume19
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 1 Jan 2012

Keywords

  • anaemia
  • chronic hepatitis C
  • drug interaction
  • influenza A

Fingerprint

Dive into the research topics of 'Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: A new drug interaction?'. Together they form a unique fingerprint.

Cite this